Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
Dendrites help neuroscientists see the forest for the trees
Dendritic arbors provide just the right scale to study how individual neurons reciprocally interact with their broader circuitry—and are our best bet to bridge cellular and systems neuroscience.
Dendrites help neuroscientists see the forest for the trees
Dendritic arbors provide just the right scale to study how individual neurons reciprocally interact with their broader circuitry—and are our best bet to bridge cellular and systems neuroscience.
By
Justin O’Hare
27 February 2026 | 7 min read
Two primate centers drop ‘primate’ from their name
The Washington and Tulane National Biomedical Research Centers—formerly called National Primate Research Centers—say they made the change to better reflect the breadth of research performed at the centers.
Two primate centers drop ‘primate’ from their name
The Washington and Tulane National Biomedical Research Centers—formerly called National Primate Research Centers—say they made the change to better reflect the breadth of research performed at the centers.
By
Calli McMurray
26 February 2026 | 5 min read
Post-infection immune conflict alters fetal development in some male mice
The immune-conflict between dam and fetus could help explain sex differences in neurodevelopmental conditions.
Post-infection immune conflict alters fetal development in some male mice
The immune-conflict between dam and fetus could help explain sex differences in neurodevelopmental conditions.
By
Viviane Callier
26 February 2026 | 5 min read